Teri F. Willey (She/Her)

Revolutionizing healthcare as pioneers in non-invasive neurostimulation solutions. At Spark Biomedical, we are defined by our boldness, agility, and collaborative spirit. Committed to unlocking the potential of neurostimulation technology for diverse health challenges. We aim to equip providers and researchers with innovative, evidence-based solutions that redefine approaches to treatment -- inspired by our commitment to offer more to patients. Our journey began in Dallas in 2018, where we broke barriers with the Sparrow Therapy System, the first generation of our safe, comfortable, drug-free, and FDA-cleared approach to treating opioid withdrawal symptoms. Today, our second-generation device, Sparrow Ascent is spreading its wings and expanding its impact as we explore more ways to bend the curve on opioid addiction. We are Spark Biomedical – a center for groundbreaking neurostimulation technology, cutting-edge scientific research, and compassionate patient support. We are Spark Biomedical and we’re here to change the world.

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

The Mill is 19,000 square feet of coworking and business incubator space located in the Trades District in downtown Bloomington, Indiana. Our mission is to launch and accelerate high-potential companies, and our vision is to become the center of coworking and entrepreneurship in Indiana. We have been producing events and programming to support the technology and innovation community since summer 2017, and renovation of the 111-year-old building was completed in fall 2018. Operating as a 501(c)(3), we build the infrastructure that technology and innovation entrepreneurs need to be successful.

Vascugen is dedicated to revolutionizing the standard of care for millions of patients suffering from severe conditions caused by restricted blood flow, particularly for those patients at high risk for amputation and death for whom few to no treatment options remain. The company’s lead product is an allogeneic vasculogenic cell – a cell with the potential to forge new blood vessels in oxygen-starved tissues. The vasculogenic cell product is manufactured from induced pluripotent stem cells (iPSCs), which provide a limitless source from which to produce off-the-shelf, cryopreserved doses at scale.

Periodic builds enterprise software tailored to the specific use cases of each business on our platform. We excel at systems whose core functioning requires advanced booking and scheduling features including the ability to build forms, send messages and process payments. Typically our customers are managing multiple locations and coordinating the schedules of large teams. Advanced features allow you to book and purchase services online with a shopping cart like experience, thus bringing e-commerce to services. Businesses that are looking for full website integration with time and resource management will enjoy the robust feature set and our "done with you" customer service approach, giving you the help and guidance you need to build an amazing app. A great fit for us would be a company with a complex schedule with multiple people and locations. We can also handle event scheduling. If interested in working with Periodic you can visit our website and book a discovery call to talk with our sales team about your project. If interested in employment, periodic offers a competitive salary with benefits available to all full-time staff. We employ full-stack developers, customer support managers, account executives and platform specialists. We are regularly looking for people with creative energy, an honest heart, a responsive disposition, who is others focused and neat. You can learn more about our company as both a prospective customer or employee by visiting periodic.is.

Diagnotes is a mobile platform for health systems that accelerates clinical communication and gives your care teams the power to collaborate seamlessly in real time. The result: increased clinician and patient satisfaction, and reduced cost.

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an entirely new approach to treating severe diseases. We are initially focused on diseases of the central nervous system and the eye, with an emphasis on haploinsufficiencies, which are diseases caused by a loss of about half of the normal protein function. Rather than replace, repair or edit faulty genes, we aim to increase – or stoke – protein output from healthy genes to restore functional protein levels using our proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform. In all, Stoke has identified ~6500 genes with a TANGO signature, representing broad potential for our approach to help people with severe diseases. The early results have been promising. Stoke’s first medicine in development, STK-001 has demonstrated positive Phase 1/2 results for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy that is associated with a number of debilitating non-seizure comorbidities. Behind that, is STK-002, a potential treatment for autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. Clinical studies of STK-002 are anticipated to start in 2024. The company is pursuing potential treatments for three additional neurodevelopmental disorders, including Syngap1 and Rett syndrome, in collaboration with Acadia Pharmaceuticals. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.

Revolutionizing healthcare as pioneers in non-invasive neurostimulation solutions. At Spark Biomedical, we are defined by our boldness, agility, and collaborative spirit. Committed to unlocking the potential of neurostimulation technology for diverse health challenges. We aim to equip providers and researchers with innovative, evidence-based solutions that redefine approaches to treatment -- inspired by our commitment to offer more to patients. Our journey began in Dallas in 2018, where we broke barriers with the Sparrow Therapy System, the first generation of our safe, comfortable, drug-free, and FDA-cleared approach to treating opioid withdrawal symptoms. Today, our second-generation device, Sparrow Ascent is spreading its wings and expanding its impact as we explore more ways to bend the curve on opioid addiction. We are Spark Biomedical – a center for groundbreaking neurostimulation technology, cutting-edge scientific research, and compassionate patient support. We are Spark Biomedical and we’re here to change the world.

Pathway to Cures (P2C) is a venture philanthropy fund created specifically to accelerate the development of cures across all inheritable blood disorders. As a flexible partner working collaboratively with other organizations, P2C makes investments in innovative therapies and technologies, leveraging the deep resources and scientific community relationships of the National Hemophilia Foundation (NHF). By reinvesting proceeds from investments back into the Fund, P2C will amplify our impact by supporting the progress of promising companies and building a deep and diverse portfolio of investments that further our mission.

Seen. Heard. Funded. Excellence knows no skin color, gender, sexual orientation or geography. But 90% of venture capital goes to people who look alike and live nearby. No more. Sixty8 Capital is shining a light on undercapitalized founders and innovators in the flyover states to even the game, impact the world, and generate massive venture returns. It’s past time – let’s make the change.

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

The Mill is 19,000 square feet of coworking and business incubator space located in the Trades District in downtown Bloomington, Indiana. Our mission is to launch and accelerate high-potential companies, and our vision is to become the center of coworking and entrepreneurship in Indiana. We have been producing events and programming to support the technology and innovation community since summer 2017, and renovation of the 111-year-old building was completed in fall 2018. Operating as a 501(c)(3), we build the infrastructure that technology and innovation entrepreneurs need to be successful.